April 27, 2020

Defendify case study

Xolair pitch leave behind

Genentech | Novartis

Xolair pitch leave behind

Alnylam | Fitusiran

Alnylam AOR Fitusiran pitch

Eisai | Helsinn

Akynzeo VR / UI

Novartis | Afinitor

AFINI-Classics: PNETman